Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Steven Rosenberg. (2001) New developments in the urokinase-type plasminogen activator system. Expert Opinion on Therapeutic Targets 5:6, pages 711-722.
Read now
Read now
Articles from other publishers (34)
Alison Betts, Tracey Clark, Paul Jasper, John Tolsma, Piet H. van der Graaf, Edmund I. Graziani, Edward Rosfjord, Matthew Sung, Dangshe Ma & Frank Barletta. (2020) Use of translational modeling and simulation for quantitative comparison of PF-06804103, a new generation HER2 ADC, with Trastuzumab-DM1. Journal of Pharmacokinetics and Pharmacodynamics 47:5, pages 513-526.
Crossref
Crossref
Meng Liu, Ling-ling Sun, Ying-jun Li, Heng-yuan Li, Jian Zhang, Bing-hao Li & Zhao-ming Ye. (2015) Trastuzumab enhanced the cytotoxicity of Vγ9Vδ2 T cells against zoledronate-sensitized osteosarcoma cells. International Immunopharmacology 28:1, pages 160-167.
Crossref
Crossref
Lynsey M Whilding & John Maher. (2015) ErbB-targeted CAR T-cell immunotherapy of cancer. Immunotherapy 7:3, pages 229-241.
Crossref
Crossref
John M. Lambert & Ravi V. J. Chari. (2014) Ado-trastuzumab Emtansine (T-DM1): An Antibody–Drug Conjugate (ADC) for HER2-Positive Breast Cancer. Journal of Medicinal Chemistry 57:16, pages 6949-6964.
Crossref
Crossref
William Kong, Ted Richards, Jin Q. Cheng & Domenico Coppola. 2014. Molecular Pathology and Diagnostics of Cancer. Molecular Pathology and Diagnostics of Cancer
57
73
.
Akiyo Koshiyama, Tomoko Ichibangase & Kazuhiro Imai. 2013. Quantitative Proteome Analysis. Quantitative Proteome Analysis
1
16
.
Dharmender Rathee, Madhavi Thanki, Satish Bhuva, Sheetal Anandjiwala & Reena Agrawal. (2013) Iridoid glycosides-Kutkin, Picroside I, and Kutkoside from Picrorrhiza kurroa Benth inhibits the invasion and migration of MCF-7 breast cancer cells through the down regulation of matrix metalloproteinases. Arabian Journal of Chemistry 6:1, pages 49-58.
Crossref
Crossref
Pravin TP KaumayaKevin Chu Foy. (2012) Peptide vaccines and peptidomimetics targeting HER and VEGF proteins may offer a potentially new paradigm in cancer immunotherapy. Future Oncology 8:8, pages 961-987.
Crossref
Crossref
Y. Lu & S.-H. Yu. 2010. Physical Properties and Applications of Polymer Nanocomposites. Physical Properties and Applications of Polymer Nanocomposites
638
e697
.
Nabil Ahmed, Vita S Salsman, Eric Yvon, Chrystal U Louis, Laszlo Perlaky, Winfried S Wels, Meghan K Dishop, Eugenie E Kleinerman, Martin Pule, Cliona M Rooney, Helen E Heslop & Stephen Gottschalk. (2009) Immunotherapy for Osteosarcoma: Genetic Modification of T cells Overcomes Low Levels of Tumor Antigen Expression. Molecular Therapy 17:10, pages 1779-1787.
Crossref
Crossref
Jing Wan, Peter Sazani & Ryszard Kole. (2009) Modification of HER2 pre-mRNA alternative splicing and its effects on breast cancer cells. International Journal of Cancer 124:4, pages 772-777.
Crossref
Crossref
Ramon Colomer. (2008) Vacunas y cáncer de mama. Medicina Clínica 131:18, pages 692-693.
Crossref
Crossref
Kazuhiro Imai, Tomoko Ichibangase, Ryoichi Saitoh & Yutaka Hoshikawa. (2008) A proteomics study on human breast cancer cell lines by fluorogenic derivatization–liquid chromatography/tandem mass spectrometry. Biomedical Chromatography 22:11, pages 1304-1314.
Crossref
Crossref
Hubert Hondermarck, Christophe Tastet, Ikram El Yazidi-Belkoura, Robert-Alain Toillon & Xuefen Le Bourhis. (2008) Proteomics of Breast Cancer: The Quest for Markers and Therapeutic Targets. Journal of Proteome Research 7:4, pages 1403-1411.
Crossref
Crossref
Rosalia Rabinovsky, Jonathan W. Uhr, Ellen S. Vitetta & Eitan Yefenof. 2007.
189
202
.
Ebony Boyce, Elise C. Kohn & Gordon B. Mills. 2006. Breast Cancer and Molecular Medicine. Breast Cancer and Molecular Medicine
623
639
.
E.A. BOYCE & E.C. KOHN. (2005) Ovarian cancer in the proteomics era: diagnosis, prognosis, and therapeutics targets. International Journal of Gynecological Cancer 15:s3, pages 266-273.
Crossref
Crossref
Deborah A. Ferguson, Matthew R. Muenster, Qun Zang, Jeffrey A. Spencer, Jeoffrey J. Schageman, Yun Lian, Harold R. Garner, Richard B. Gaynor, J. Warren Huff, Alexander Pertsemlidis, Raheela Ashfaq, John Schorge, Carlos Becerra, Noelle S. Williams & Jonathan M. Graff. (2005)
Selective Identification of Secreted and Transmembrane Breast Cancer Markers using
Escherichia coli
Ampicillin Secretion Trap
. Cancer Research 65:18, pages 8209-8217.
Crossref
Crossref
Michael R. Verneris, Arash Arshi, Matthias Edinger, Martin Kornacker, Yaso Natkunam, Mobin Karami, Yu-an Cao, Neyssa Marina, Christopher H. Contag & Robert S. Negrin. (2005) Low Levels of Her2/neu Expressed by Ewing's Family Tumor Cell Lines Can Redirect Cytokine-Induced Killer Cells. Clinical Cancer Research 11:12, pages 4561-4570.
Crossref
Crossref
Agn�s Journet & Myriam Ferro. (2004) The potentials of MS-based subproteomic approaches in medical science: The case of lysosomes and breast cancer. Mass Spectrometry Reviews 23:6, pages 393-442.
Crossref
Crossref
Yong Li, Paul J Cozzi, Chang F Qu, David Y Zhang, Syed M Abbas Rizvi, Chand Raja & Barry J Allen. (2004) Cytotoxicity of human prostate cancer cell lines in vitro and induction of apoptosis using 213Bi-Herceptin α-conjugate. Cancer Letters 205:2, pages 161-171.
Crossref
Crossref
Eric K. Rowinsky. (2004) The erbB Family: Targets for Therapeutic Development Against Cancer and Therapeutic Strategies Using Monoclonal Antibodies and Tyrosine Kinase Inhibitors. Annual Review of Medicine 55:1, pages 433-457.
Crossref
Crossref
Oday Hamid. (2004) Emerging Treatments in Oncology: Focus on Tyrosine Kinase (erbB) Receptor Inhibitors. Journal of the American Pharmacists Association 44:1, pages 52-58.
Crossref
Crossref
Franck Vandermoere, Ikram El Yazidi-Belkoura, Eric Adriaenssens, Jerome Lemoine & Hubert Hondermarck. 2004. Proteomics: Biomedical and Pharmaceutical Applications. Proteomics: Biomedical and Pharmaceutical Applications
139
161
.
I-H Chen, J T Chang, C-T Liao, H-M Wang, L-L Hsieh & A-J Cheng. (2003) Prognostic significance of EGFR and Her-2 in oral cavity cancer in betel quid prevalent area cancer prognosis. British Journal of Cancer 89:4, pages 681-686.
Crossref
Crossref
Laurent Dollé, Ikram El Yazidi-Belkoura, Eric Adriaenssens, Victor Nurcombe & Hubert Hondermarck. (2003) Nerve growth factor overexpression and autocrine loop in breast cancer cells. Oncogene 22:36, pages 5592-5601.
Crossref
Crossref
Kathy Miller, Gloria Meng, Jun Liu, Amy Hurst, Vanessa Hsei, Wai-Lee Wong, Rene Ekert, David Lawrence, Steven Sherwood, Laura DeForge, Jacques Gaudreault, Gilbert Keller, Mark Sliwkowski, Avi Ashkenazi & Leonard Presta. (2003) Design, Construction, and In Vitro Analyses of Multivalent Antibodies. The Journal of Immunology 170:9, pages 4854-4861.
Crossref
Crossref
Hubert Hondermarck. (2003) Breast Cancer. Molecular & Cellular Proteomics 2:5, pages 281-291.
Crossref
Crossref
Zhao Rui, Ji Jian‐Guo, Tong Yuan‐Peng, Pu Hai & Ru Bing‐Gen. (2003) Use of serological proteomic methods to find biomarkers associated with breast cancer. PROTEOMICS 3:4, pages 433-439.
Crossref
Crossref
M G Sacco, S Soldati, E Mira Cató, L Cattaneo, G Pratesi, E Scanziani & P Vezzoni. (2002) Combined effects on tumor growth and metastasis by anti-estrogenic and antiangiogenic therapies in MMTV-neu mice. Gene Therapy 9:19, pages 1338-1341.
Crossref
Crossref
Ikram El Yazidi-Belkoura, Eric Adriaenssens, Anne-Sophie Vercoutter-Edouart, J?r?me Lemoine, Victor Nurcombe & Hubert Hondermarck. (2016) Proteomics of Breast Cancer: Outcomes and Prospects. Technology in Cancer Research & Treatment 1:4, pages 287-295.
Crossref
Crossref
Koji Kono, Akihiro Takahashi, Hideki Amemiya, Fumiko Ichihara, Hidemitsu Sugai, Hidehiko Iizuka, Hideki Fujii & Yoshiro Matsumoto. (2002) Frequencies of HER-2/neu overexpression relating to HLA haplotype in patients with gastric cancer. International Journal of Cancer 98:2, pages 216-220.
Crossref
Crossref
Robert A Wolff. (2002) Exploiting molecular targets in pancreatic cancer. Hematology/Oncology Clinics of North America 16:1, pages 139-157.
Crossref
Crossref
Eric Pluygers, Ala Sadowska, Lech Chyczewski, Jacek Nikliński, Wiesława Niklińska & Elżbieta Chyczewska. (2001) The impact of immune responses on lung cancer and the development of new treatment modalities. Lung Cancer 34, pages S71-S77.
Crossref
Crossref